Regulatory guidance,
read the source
A curated reading list of official regulatory guidance and legal analysis on telehealth medical practice, therapeutic goods advertising law, and Ahpra prescribing standards in Australia. Drawn from the regulators themselves and from the country’s leading health-law firms.
Each entry below links verbatim to its original publisher. Quiet Hours offers no editorial opinion on the content — these pages are reproduced here because we believe readers are entitled to read the same regulatory guidance that binds their healthcare providers.
Dispensed Pty Ltd issued infringement notices and directed to cease alleged unlawful advertising of medicinal cannabis
Six infringement notices totalling $118,800 issued over indirect advertising on third-party sites and social media — including the use of terms such as 'plant medicine' and 'cannabinoid-based therapies', which the TGA treats as synonymous with medicinal cannabis.
Advertising medicinal cannabis products is prohibited
Official TGA guidance on prohibited advertising of prescription-only medicines, including the reasonable-consumer test and examples of indirect promotion.
Advertising a health service — what you can and cannot do
Reminder: supply and advertising controls on medicinal cannabis
What can and cannot be advertised to the general public
Updated medicinal cannabis guidance
Advertising guidance for businesses dealing with medicinal cannabis (PDF)
Planned consultation to address growing safety concerns of unapproved medicinal cannabis products in Australia
The TGA announces a public consultation prompted by increasing concern over the safety of unapproved medicinal cannabis products — including ingestible dose forms and those containing higher levels of THC.
All medicinal cannabis products supplied to Australian patients must meet quality standards
A media release reaffirming that every medicinal cannabis product supplied in Australia — whether manufactured domestically or imported, and regardless of dose form — must comply with Therapeutic Goods Order 93 (TGO 93).
Complying with the quality requirements for medicinal cannabis
Guidance on TGO 93, covering dose-form quality, testing, labelling, manufacturing requirements, and the child-resistant packaging obligations that apply to ingestible formats.
Guidance on medicinal cannabis prescribing targets unsafe practice
Ahpra and the National Boards issue direct guidance criticising online questionnaire-based cannabis prescribing, single-product clinics, and any model that skips a real-time consultation with a practitioner before a script is written.
Guidance on medicinal cannabis prescribing targets unsafe supply
Ahpra's follow-up statement sharpening its focus on supply-side concerns — unsafe dispensing pathways, single-product prescribing models, and the supply chain behind them.
Patient safety paramount in updated telehealth guidance
Ahpra records 586 telehealth-related notifications in 2024–25 and updates its guidance accordingly. Prescribing on the basis of a text, email, or online questionnaire — without a real-time consultation — is identified as poor practice.
Medicinal cannabis prescribing guidance
The foundational Ahpra guidance for prescribers outlining obligations around patient assessment, advertising, and clinical decision-making.
Ahpra publishes cannabis prescriber guidance
Regulators crack down on therapeutic goods advertising: TGA, ACCC and Ahpra actions
Breaking down the dose: understanding the laws regulating advertising medicines in Australia
TGA Regulations and Medicinal Cannabis Advertisement
Prescribing medicinal cannabis: be aware of the medico-legal risks
Updated guidelines for the prescribing of medicinal cannabis
Health-law commentary on Ahpra's 2025 guideline update, including how the regulator now expects prescribers to treat telehealth-first cannabis models.
On this reading list
The entries above are linked verbatim to their original publishers and are reproduced here as-is. Quiet Hours offers no editorial opinion on their content. We feature them because we believe readers are entitled to read the same regulatory guidance that their healthcare providers are bound by. If you would like to understand the legal framework that governs telehealth medical practice in Australia, we encourage you to read the official sources directly.